Skip to content
10-Q

Quarterly Report

Q Therapeutics, Inc.

0001193125-15-291454

← back to feed
Filed
Aug 14, 2015 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 14, 2015 30.83M sh
Capex Q2 2015 · Jun 30, 2015 $1.39K
Capex Q2 2015 · Jun 30, 2014 $5.62K
Operating Cash Flow Q2 2015 · Jun 30, 2015 −$833.33K
Operating Cash Flow Q2 2015 · Jun 30, 2014 −$752.05K
Cash And Equivalents Q2 2015 · Jun 30, 2015 $111.43K
Cash And Equivalents Q2 2015 · Dec 31, 2014 $707.01K
Cash And Equivalents Q2 2015 · Jun 30, 2014 $1.4M
Cash And Equivalents Q2 2015 · Dec 31, 2013 $142.53K
Stockholders Equity Q2 2015 · Jun 30, 2015 −$1.38M
Stockholders Equity Q2 2015 · Dec 31, 2014 −$295.85K
Current Liabilities Q2 2015 · Jun 30, 2015 $1.56M
Current Liabilities Q2 2015 · Dec 31, 2014 $1.04M
Current Assets Q2 2015 · Jun 30, 2015 $155.49K
Current Assets Q2 2015 · Dec 31, 2014 $721.74K
Total Assets Q2 2015 · Jun 30, 2015 $178.38K
Total Assets Q2 2015 · Dec 31, 2014 $748.31K
Sga Expense Q2 2015 · Jun 30, 2015 $541.37K
Sga Expense Q2 2015 · Jun 30, 2015 $1.1M
Sga Expense Q2 2015 · Jun 30, 2014 $468.87K
Sga Expense Q2 2015 · Jun 30, 2014 $1.05M
Rd Expense Q2 2015 · Jun 30, 2015 $261.02K
Rd Expense Q2 2015 · Jun 30, 2015 $488.18K
Rd Expense Q2 2015 · Jun 30, 2014 $782.94K
Rd Expense Q2 2015 · Jun 30, 2014 $1.27M
Net Income Q2 2015 · Jun 30, 2015 −$806.68K
Net Income Q2 2015 · Jun 30, 2015 −$1.57M
Net Income Q2 2015 · Jun 30, 2014 −$735.03K
Net Income Q2 2015 · Jun 30, 2014 −$1.9M
Operating Income Q2 2015 · Jun 30, 2015 −$802.4K
Operating Income Q2 2015 · Jun 30, 2015 −$1.59M
Operating Income Q2 2015 · Jun 30, 2014 −$749.99K
Operating Income Q2 2015 · Jun 30, 2014 −$1.82M
Gross Profit Q2 2015 · Jun 30, 2014 $501.82K
Gross Profit Q2 2015 · Jun 30, 2014 $501.82K
Cost Of Revenue Q2 2015 · Jun 30, 2014 $800
Cost Of Revenue Q2 2015 · Jun 30, 2014 $800